Paul R. Fonteyne assumed the role of US Country Managing Director and President and CEO of Boehringer Ingelheim USA Corporation on January 1, 2012.
Prior to assuming his present role he was the US Corporate Senior Vice President, Corporate Division Marketing, Prescription Medicines and led the global marketing strategy supporting Boehringer Ingelheim’s Prescription Medicines Business, based in Ingelheim Germany. In this position, Paul led the global marketing teams that prepared for launches of new medicines worldwide, and managed the entire BI Prescription Medicines portfolio worldwide. Paul was a member of all global governance bodies related to the Prescription Medicines Business of BI.
Paul Fonteyne joined Boehringer Ingelheim Pharmaceuticals Inc. in 2003 as Executive Vice President and Head of Marketing and Sales of BI US. He was a member of the Boehringer Ingelheim Corporation’s Corporate Management Committee and is responsible for the Prescriptions Medicines business in the US.
Prior to joining BI, Paul worked for Merck & Co. and Abbott Laboratories in positions of increasing responsibility in Marketing & Sales.
Born in Brussels, Belgium, Paul was awarded an MS in Chemical Engineering from the University of Brussels in 1985 and an MBA from Carnegie Mellon University in 1987. Paul became a US citizen in 1988.
Currently Paul serves on the Board of Pharmaceutical Research and Manufacturers of America, Washington, D.C. In the past he served as Chairman of the Board of the National Pharmaceutical Council, an industry group focused on demonstrating the value of pharmaceutical products. He is also on the Bio Advisory Board of the Kellogg School of Management (Northwestern University).
Paul resides in Westport, CT with his wife, Nathalie, and three children.